32
Views
11
CrossRef citations to date
0
Altmetric
Special Contributions

The Role of Asbestos Fiber Dimensions in the Prevention of Mesothelioma

Pages 64-69 | Published online: 20 Nov 2013

References

  • Chiappino G. Mesotelioma: ii tuolo delle fibre ultrafini e con-seguenti riflessi in campo preventivo e mediclo legale. Med Lay. 2005; 96: 3–23. [In Italian]
  • Paoletti L, Falchi M, Batisti D, Zappa M, Chellini E, Biancalani M. Characterization of asbestos fibers in pleural tissue from 21 cases of mesothelioma. Med Lay. 1993; 84: 373–8. [In Italian]
  • Boutin C, Dumortier P, Rey F, Vialat JR, De Vuyst P. Black spots concentrate oncogenic asbestos fibers in the parietal pleura. Thoracoscopic and mineralogic study. Am J Respir Crit Care. 1996; 153: 4449.
  • Suzuki Y, Yuen SR. Asbestos fibers contributing to the induction of human malignant mesothelioma. Ann NY Acad Sci. 2002; 982: 160–76.
  • Suzuki Y, Yuen SR. Asbestos tissue burden study on human malignant mesothelioma. Ind Health. 2001; 39: 150–60.
  • Suzuki Y, Yuen SR, Ashley R Short, thin asbestos fibers con-tribute to the development of human malignant mesothelioma: pathological evidence. Int J Hyg Environ Health. 2005; 208: 201–10.
  • Mitchev K, Dumortier P, De Vuyst P. “Black spots” and hyaline pleural plaques on the parietal pleura of 150 urban necropsy cases. Am J Surg Pathol. 2002; 26: 1198–206.
  • Levin SM, Kann PE, Lax MB. Medical examination for asbestos-related disease. Am J Ind Med. 2000; 37: 6–22
  • Peacock C, Copley SJ, Hansell DM. Asbestos-related benign pleural disease. Clin Radio'. 2000; 55: 422–32.
  • Gibbs AR, Stephens M, Griffiths DM, Blight BJN, Pooley D. Fiber distribution in the lungs and pleura of subjects with asbestos related diffuse pleural fibrosis. Br J Ind Med. 1991; 48: 762–70.
  • Dodson RF, Williams MG, Corn CJ, Brollo A, Bianchi C. Asbestos content of lung tissue, lymph nodes, and pleural plaques from former shipyard workers. Am Rev Respir Dis. 1990; 142: 843–7.
  • Dodson RF, O'Sullivan MF, Huang J, Holiday DB, Hammar SP. Asbestos in extrapulmonary sites-omentum and mesentery. Chest 2000; 117: 486–93.
  • Godwin NIVIC, Jagatic J. Asbestos and mesothelioma. Environ Res. 1970; 3: 391–416.
  • Cunningham HM, Pontefract RD. Placental transfer of asbestos. Nature. 1974; 249: 177–8.
  • Lawerrys JM, Baret JH. Alveolar clearance and the role of the pulmonary lymphatics. Am Rev Respir. Dis. 1977: 625–83.
  • Brody AR, Hill LH. Interstitial accumulation of inhaled chrysotile asbestos fibers and consequent formation of micro-calcification. Am J Pathol. 1982; 109: 107–14.
  • Viallat JR, Raybuad F, Passarel M., et al Pleural migration of chrysotile fibers after intratracheal injection in rats, Arch Envi-ron Health. 1986; 41: 282–6.
  • Dodson RF, Williams MG, Corn CJ. A comparison of asbestos burden in lung parenchyma, lymphnodes and plaques. Ann NY Acad Sci. 1991; 643: 53–60.
  • Hague AK, Vrazel DM, Burau 1(13. Is there transplacental trans-fer of asbestos? A study of 40 stillborn infants. Pediatr Pathol. 1996;877-92.
  • Lippman M. Effects of fiber characteristics on lung deposition, retention, and disease. Environ Health Perspect. 1990; 88: 311–7.
  • Dodson RF, Atkinson MA, Levin JL. Asbestos fiber lenght as related to potential pathogenicity: a critical revue, Am J Ind Med. 2003; 44: 291–7
  • Roggli VL, Sharma A. Analysis of tissue mineral fiber content, In: Roggli VL, Oury TD, Sporn TA (eds). Pathology of Asbestos-associated Diseases. New York: Springer, 2004: 309-54.
  • Wagner JC, Sleggs CA, Marchand P. Diffuse pleural mesothe-lioma and asbestos exposure in the North Western Cape Province. Br J Ind Med. 1960; 17: 260–71.
  • Vigliani EC, Mottura G-, Maranzana P. Association of pul-monary tumors with asbestosis in Piedmont and Lombardy. Ann NY Acad Sci. 1965; 132: 558–74.
  • International Agency for Research on Cancer (IARC). IARC monographs on the evaluation of the carcinogenic risks of chemicals to humans. Volume 14. Asbestos. Lyon, France; IARC, 1977.
  • Bertazzi PA, Piolatto G. Epidemiologia mondiale e italiana. In: Mesotelioma Maligno,Torino, Italy: Regione Piemonte Editore, 1985: 18-31. [In Italian]
  • Scansetti G, Piolatto G, Pira E. Ii rischio da amianto oggi. Torino, Italy: Regione Piemonte Editore, 1985. [In Italian]
  • Gardner 11/11, Saracci R. Effects on health of non-occupational exposure to airborne mineral fibers. In: Mignon J, Peto J, Saracci R (eds). Non-occupational Exposure to Mineral Fibers. IARC Scientific Publication No. 90, Lyon, France: IARC, 1989: 375–97.
  • De Vos Irvine H, Lamont DW, Hole DJ, Gillis CR. Asbestos and lung cancer in Glasgow and the West of Scotland. Br J Med. 1993; 306;1503–6.
  • Hillerdal G. Mesothelionta: cases associated with non-occupa-tional and low dose exposures. Occup Environ Med. 1999; 56: 505–13.
  • Browne K. Asbestos related malignancy and the Cairns hypoth-esis. Br J Ind Med. 1991; 48: 73–6.
  • Iwatsubo Y, Pairon JC, Boutin C et al. Pleural mesothelioma: dose-response relation at low levels of asbestos exposure in a French population-based case-control study. Am J Epidemiol. 1998; 148: 133–42.
  • Doll R., Peto J. Asbestos: Effects on Health of Exposure to Asbestos. London, U.K.; Health and Safety Commission, HMSO, 1985.
  • Selikoff IJ. Asbestos-associated disease. In: Rosenau M (ed), Public Health and Preventive Medicine. 11th ed. New York: Appleton-Century-Crofts, 1986: 568–98.
  • Motley RL, Patrick OAT Jr, McGuiness Keane A. Medico-legal aspects of asbestos-related diseases; a plaintiffs attorney's per-spective. In: Roggli VL, Oury TD, Sporn TA. Pathology of Asbestos-associated Diseases, New York: Springer, 2004: 355401.
  • Illgren ER, Browne K. Asbestos related mesothelioma; evidence for a threshold in animals and human, Regul Toxicol Pharnia-col. 1991; 13: 116–32
  • Hodgson JT, Darnton A. The quantitative risk of mesothelioma and lung cancer in relation to asbestos exposure, Ann Occup Hyg. 2000;565-601.
  • McDonald JC, Armstrong B, Case B, et al, Mesothelioma and asbestos fiber type: evidence from lung tissue. Cancer, 1989; 63: 1544–7.
  • Rôdelsperger K, Woitowitz HJ, Brfickel B, Arhelger R, Pohla-beln H, peke' KH. Dose-response relationship between amphi-bole fiber lung burden and mesothelioma. Cancer Detect Prey. 1999; 23: 183–93.
  • Rogers A, Leigh J, Berry G, Fergusond A, Mulder HB, Ackad M. Relationship between lung asbestos fiber type and concentra-tion and relative risk of mesothelioma. Cancer. 1991;67;1912–20.
  • Newhouse ML. A study of the mortality of workers in an asbestos factory. Br J Ind Med. 1969; 26: 294–301.
  • Newhouse ML, Berry G. Predictions of mortality from mesothe-lial tumors in asbestos factory workers. Br J Ind Med. 1976; 33: 147–51.
  • Seidman H, Selikoff IJ, Hammond EC. Short-term asbestos work exposure and long term observation. Ann NY Acad Sci. 1979; 330: 61–89.
  • Leigh J, Davidson P, Hendri L, Berry D. Malignant mesothe-Rona in Australia, 1945-2000, Arn J Ind Med, 2000; 41: 188–201
  • Neumann V, Gunthe 8, Mulle KM, Fisher M. Malignant mesotheliona-German mesothelioma register 1987-1999. Arch Occup Environ Health. 2001; 74: 393–5.
  • Bianchi C, Girelli L, Grandi G, Brillo A, Ramarti L, Zuch C. Eur J Cancer Prey. 1997; 6: 162–6.
  • Hutchings S, Jones J, Hodgson J. Asbestos related disease. In; Driver F(ed). Occupational Health, Decennal Supplement. The Registar General's decennal supplement for England and Wales, London, U.K.: HMSO, 1995: 127-48
  • Peto J, Seidman H, Selikoff IJ. Mesothelionia mortality in asbestos workers: implications for model of carcinogenesis and risk assessment. Br J Cancer. 1982;45:12435
  • Goldberg M. Amiante et risque de cancer; relations exposi-tions-effets pour les popolations professionnellment exposees, Arch Mal Prof. 1999; 60: 278–85. [In French]
  • Browne K. Asbestos-related disorders. In: Parkes WR (ed). Occupational Lung Disorders. 3rd ed, 1995 revised reprint. Oxford, U.K.: Butterworth-Heinernann,1995: 411-504
  • Berry G, Newhouse ML, Wagner JC. Mortality from all cancers of asbestos factory workers in east London 1933-80. Occup Env-iron Med, 200057;782-5.
  • Mowe' G, Gylseth B, Hartveit F, Skaug V. Fiber concentration in lung tissue of patients with malignant mesothelioma. A case-control study. Cancer. 1985; 56: 1989–2093.
  • Tuomi T, Huuskonen MS, Virtamo M., et al Relative risk of mesothelioma associated with different levels of exposure, Scand J Work Environ Health. 1991; 17: 404–8.
  • Berry G. Models for mesothelioma incidence following expo-sure to fibers in terms of timing and duration of exposure and the biopersistence of these fibers. Inhal Toxicol, 1999;11;111–30.
  • Rogers AJ, Leigh MB, Berry G, Ferguson A, Mulder HB, Ackad M. Relationship between lung asbestos fiber type and concen-tration and relative risk of mesothelioma. A case-control study. Cancer. 1991; 67: 1912–20.
  • Davis JMG, McDonald JC, Low level exposure to asbestos; is there a risk? Br J Ind Med. 1988; 45: 505–8.
  • Pott F, Roller M, Ziem, et al. Carcinogenicity studies on natural and man-made fibers with intraperitoneal test in rats. In; Bignon J, Peto J, Saracci R (eds), Non-occupational Esposure to Mineral Fibers. Lyon, France: IARC Scientific Publication No. 90,1989: 173-9.
  • Governa M, Amati M, Fontana 8, et al. Role of the iron in asbestos-body-induced oxidant radical generation. J Toxicol Environ Health. Part A. 1999;58; 279–87.
  • Collins VP, Loeffler RK, Tivey H. Observations on growth rates of human tumours. Arn J Roentgenol Radio' Then 1956;76; 988
  • Tannock IF. Biology and the tumor growth. Hosp Pract, 1983; 18: 91–3.
  • Flora S, Vannucci A. La prevenzione primaria dei tumori. Pro-fessione: Santa Pubbfica e IVIedicina Pratica. 19964:46,53. [In Italian]
  • Conan RS, Kumar V, Collins T, Neoplasia, In: Cotran RS, Kumar V, Robbins SL (eds), Robbins Pathologic Basis of Disease, Philadelphia, PA: W. B. Saunders, 1999: 300-1.
  • Bregui M, Siena S, Bonaclonna G. Principi di prohferazione eel-'Ware, In: Bonadonna G, Robustelli G, della Cuna M (ects), Meclicina Oncologica. Milano, Italy: Masson, 2000: 73-115. [In Italian}
  • Hansen J, de Klerk NH, Musk AMT, Hobbs MST. Environmental exposure to crocidolite and mesotheliorna: exposure—response relationships. Am J Respir Grit Care Med, 1998; 57: 9–75.
  • Roushdy-Harrimady I, Siegel J, Ernri S., et al Genetic susceptibil-ity factor and malignant mesothelioma in the Cappadocia region of Turkey. Lancet, 2001; 357: 444.5.
  • Saracci R, Simonato L. Familial malignant mesotheliama. Lancet. 2001; 358: 1813–4.
  • Thierne B. I sistemi di aspirazione localizzata per la bonifica clegli ambienti di lavaro. Milano, Italy: Clinica del Lavoro Devoto, 1980. [In Italian]
  • Committee on Industrial Ventilation. Industrial Ventilation: A Manual of Recommended Practice, 11th ed. Michigan, Ameri-can Conference of Governmental Industrial Hygienists, 1970.
  • Plebani C, Di Luigi M, Caponi M. Efficienza di filtrazione di filth antipolvere utilizzati nei respiratori in funzione della gran-ulornetrica clelEaerosol. Giornak degli Igienisti Indnstriali 2005; 30: 253–9. [in Italian]
  • Spurny K.vetoslay K (er1). Advances in Aerosol Filtration, Boca Raton, FL: CRC Press. 1998.
  • Chen CC, Lettimaki M, Willike K, Aerosol penetration through filtering facepieces and respirator cartridges. Am Ind Hyg Assoc J, 1992;53,666,74.
  • Chen CC, Lettimaki M, Willike K. Loading and filtration char-acteristics of filtering facepieces. Ara Ind Hyg Assoc J. 1993; 54: 51–61)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.